Form 4: Helen Susan Kim Acquires Stock Options in Prothena Corp Public LTD CO
SEC Form 4 Filing
Director Helen Susan Kim acquired stock options for 20,183 ordinary shares in Prothena Corp Public LTD CO on May 14, 2025.
Summary
- Helen Susan Kim, a director of Prothena Corp Public LTD CO, acquired stock options on May 14, 2025.
- The options grant the right to buy 20,183 ordinary shares at an exercise price of $6.885.
- The options vest on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2026, assuming continuous service as a director.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an insider transaction, which is neutral in sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which is common in the biotechnology industry where stock options are frequently used as part of director compensation.
Stakeholder Impact
- The transaction could have a minor impact on shareholders by potentially diluting equity if the options are exercised in the future.
Key Dates
| Date | Description |
|---|---|
| 05/14/2025 | Date of transaction: Helen Susan Kim acquired stock options. |
| 05/16/2025 | Date of filing: Form 4 filing date. |
| 05/14/2035 | Expiration date of the stock options. |
Keywords
stock options, Form 4, director, Prothena Corp, beneficial ownership, securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.